Gene Therapy Market Size, Share, Trends, Growth Factors, and Regional Outlook To 2032

 The Gene Therapy Market is projected to grow from USD 10.8 billion in 2024 to USD 43.1 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 19.87% during the forecast period (2024 - 2032). 

Gene therapy, a ground-breaking field in the realm of medicine, is rapidly transforming the landscape of healthcare. It involves the introduction, alteration, or replacement of genetic material within an individual's cells to treat or prevent diseases. This innovative approach holds immense promise, offering potential cures for previously incurable genetic disorders and chronic conditions.

The gene therapy market is witnessing unprecedented growth, fueled by advancements in molecular biology, genetic engineering, and biotechnology. One of the key driving forces behind this growth is the convergence of gene therapy with cell therapy, creating a powerful synergy that enhances treatment efficacy across a spectrum of diseases.

Cell therapy, a pivotal component of the gene therapy landscape, involves the transplantation of living cells into a patient's body for therapeutic purposes. Stem cells, in particular, play a crucial role in regenerative medicine, offering the potential to repair damaged tissues and organs. The integration of cell therapy with gene therapy amplifies the therapeutic impact by addressing both genetic and cellular aspects of diseases. This combined approach holds tremendous potential for treating conditions such as cancer, neurodegenerative disorders, and autoimmune diseases.

Major Key Players:

Some of the Gene Therapy Companies are Amgen, Inc. (US), Novartis AG (Switzerland), Spark Therapeutics, Inc. (US), Gilead Sciences, Inc. (US), uniQure N.V. (Netherlands), Orchard Therapeutics plc (UK), Celgene Corporation (US), Bristol-Myers Squibb Company (US), Thermo Fisher Scientific Inc. (US), CEVEC (Germany), and Lonza (Switzerland).

Segment Analysis

The global gene therapy market has been segmented based on product, indication, and end user.

The market, based on product, has been divided into kymriah, luxturna, yescarta, zolgensma, strimvelis, zynteglo, imlygic, and others.

The global gene therapy market has on the basis of indication is segmented, into oncology, genetic diseases/ disorders, and others. The oncology segment is expected to hold the largest market share and to be the fastest-growing segment due to high prevalence of cancer and robust pipeline for cancer gene therapy.

The end-user segments of the market are hospitals & clinics, specialty treatment centers, and others. The hospitals & clinics segment is expected to hold the largest market share due to increasing number of hospitals. Also, hospitals are generally the first treatment choice for diseases.

Regional Analysis

The global gene therapy market is studied across four major regions: Asia-Pacific, Europe, the Americas, the Middle East, and Africa.

According to the MRFR reports, the American regional gene therapy market is likely to dominate globally over the review timeframe. The regional market's growth is driven by the rising per capita medical care consumption and the expanding pervasiveness of quality treatment. The regional market is further divided into Latin America and North America.

The European regional market will likely register substantial growth over the review timeframe. The region is further divided into Eastern Europe and Western Europe. The well-established medical infrastructure is driving the regional market's growth.

The Asia-Pacific region is projected to grow at the highest pace over the coming years. The bringing issues are driving the regional market's growth to light about the treatment strategies and growing number of patients.

Given the lack of skilled professionals and poor health infrastructure, the gene therapy market for the Middle East & African region is likely to record the CAGR over the assessment timeframe.

Browse Related Reports:

Arachnoid Cysts Market

Central Pontine Myelinolysis Market

Suture Needles  Market

Americas Blood Glucose Monitoring Market

For More Information, Please Visit @ Market Research Future

Comments

Post a Comment

Popular posts from this blog

Oligonucleotide Synthesis Market Trends, Innovations, and Growth Opportunities in the Biotechnology Landscape

  The Oligonucleotide Synthesis Market Size is projected to grow from USD 12.38 Billion in 2024 to USD 44.32 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 15.23% during the forecast period (2024 - 2032). The Oligonucleotide Synthesis market has witnessed significant growth in recent years, driven by the increasing demand for custom oligo synthesis and the expanding applications of oligonucleotides in research, diagnostics, and therapeutics. Oligonucleotides, particularly RNA oligonucleotides, play a crucial role in various biological and molecular processes, making them essential tools in the fields of genomics, proteomics, and synthetic biology. Oligonucleotide synthesis involves the chemical synthesis of short DNA or RNA sequences, commonly known as oligos. These oligos are crucial in various molecular biology applications, including polymerase chain reaction (PCR), DNA sequencing, gene synthesis , and antisense therapy. The market for oligonucleotide ...
Read more

Exploring Intimacy: The Russian Sexual Wellness Market Unveiled

  In recent years, discussions around sexual wellness have become increasingly prominent worldwide. As societal attitudes evolve, so do consumer behaviors and preferences. From traditional remedies to modern innovations, various countries are witnessing significant shifts in their sexual wellness markets. Let's delve into the landscapes of Russia, India, China, and the United States of America to understand the dynamics shaping their respective markets. Russian Sexual Wellness Market: Embracing Modernization Russia sexual wellness market  reflects a blend of traditional practices and contemporary trends. With a growing emphasis on health and well-being, Russians are increasingly open to exploring diverse products and solutions for sexual wellness. The market has witnessed a surge in the availability of contraceptives, lubricants, and intimate care products. Moreover, Russia's evolving regulatory landscape has paved the way for a wider range of offerings, including products cat...
Read more

Microfluidic Devices Market Size, Share, Analysis, Trends and Opportunities 2022 - 2030

Microfluidic Devices Market Microfluidic device, simply put, is a technology which enables the integration of several medical tests on one chip. This has turned into a crucial technology for parallelization, miniaturization, industrialization, and integration of numerous tests in diagnostics, biological research, and drug development. Microfluidic Devices Market Size is expected to reach USD 1,820.0 Million by 2030 at 17.20% CAGR during the forecast period 2022-2030 Various factors are propelling the microfluidic devices market growth. These factors, according to the latest MRFR report, include the rise in demand for point of care testing products, growing demand in proteomics and genomics, miniaturization of chips, liquid biopsies, personalized medicine, and organ-on-a-chip. Additional factors pushing market growth include rising use in drug delivery systems, especially inhalers and insulin pumps and growing awareness of the benefits of microfluidic devices. Microfluidic tech...
Read more